A synthetic heme analog that selectively inhibits HO-1 (Ki 11 nM) over HO-2 (IC50 7.5 UM) weakly inhibits eNOS and soluble guanylyl cyclase (IC50s 35 and 30 nM respectively) prevents hyperbilirubinemia in neonates by blocking HO-1 activity that increases postnatally